TMDX vs AXGN
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
TMDX · TransMedics$85.25 ▼ 9.33%
AXGN · AxoGen$55.75 ▼ 1.06%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- TMDX -39.2%
- AXGN +96.4%
Head to head
| Metric | TMDX | AXGN |
|---|---|---|
| Price | $85.25 | $55.75 |
| Change today | ▼ 9.33% | ▼ 1.06% |
| Market cap | $2.96B | $3.33B |
| Return, 3 months | -8.9% | +13.2% |
| Return, year to date | -29.9% | +70.3% |
| Return, 1 year | -34.9% | +107.5% |
| P/E (TTM) | 23.2 | – |
| P/B | 5.4 | 6.7 |
| P/E percentile vs own 5y | 67th | 14th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +41.1% | +26.2% |
| Net profit growth (YoY) | -29.8% | +229.7% |
| Gross margin | 58.6% | 74.2% |
| Operating margin | 11.9% | -5.2% |
| Net margin | 19.9% | -12.0% |
| Return on equity | 31.9% | -10.3% |
| Analyst target vs. price | +22.9% | +4.4% |
| Analyst buy share | 78% | 100% |
| RSI (14) | 52 | 66 |
| 30-day volatility | 93.1% | 95.1% |
| Max drawdown, 1 year | -58.8% | -33.1% |
| Trend read | Leaning bullish | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- AXGN is the largest of the group by market value.
- AXGN has returned the most over the past year.
- TMDX is growing revenue fastest.
- TMDX keeps the most profit per dollar of sales.
- TMDX has been the calmest stock over the last 30 days.